Reuters logo
BRIEF-Moleculin announces filing with FDA of IND for its leukemia drug Annamycin
August 29, 2017 / 11:42 AM / a month ago

BRIEF-Moleculin announces filing with FDA of IND for its leukemia drug Annamycin

Aug 29 (Reuters) - Moleculin Biotech Inc

* Moleculin announces filing with FDA of IND for its leukemia drug Annamycin

* Moleculin Biotech Inc- ‍if IND goes into effect as planned, company expects to begin clinical trials during Q4 of this year​

* Moleculin Biotech - filed with FDA investigational new drug application to study Annamycin in treatment of relapsed or refractory acute myeloid leukemia​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below